Myasthenia gravis constitutes chronic autoimmune ailment that primarily impacts the neuromuscular junction. This junction mediates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, causing weakness and fatigue in the skeletal tissues. The manifes